MCK — MCKESSON CORP

NYSE · Consumer Discretionary · Distributors · CIK 927653 ·
Last close
$878.73
Market Cap
$102.45B
52W High
$912.50
52W Low
$726.89
ADV30
1,008,238
Next earnings
2026-11-04
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 105,380,000,000 3,685,000,000 1,421,000,000 614,000,000 88,330,000,000 5,164,000,000 89,631,000,000
Mar 2026 96,295,000,000 4,044,000,000 2,248,000,000 1,682,000,000 82,323,000,000 3,975,000,000 83,157,000,000
Dec 2025 106,158,000,000 3,685,000,000 1,655,000,000 1,186,000,000 84,190,000,000 2,959,000,000 84,289,000,000
Sep 2025 103,150,000,000 3,542,000,000 1,468,000,000 1,110,000,000 84,160,000,000 4,004,000,000 84,738,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$6,155,000,000
Investing CF
$-3,432,000,000
Financing CF
$-4,631,000,000
CapEx
$-745,000,000
Dividends Paid
$-381,000,000
Buybacks
$-4,750,000,000
EPS Diluted TTM
$38.47
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$22,291,000,000
Inventory
$24,207,000,000
Receivables
$27,985,000,000
ST Investments
EBIT TTM
$6,448,000,000
Pretax Income TTM
$6,201,000,000
Interest Exp TTM
$247,000,000
Analysts
15

Yahoo Snapshot (yfinance, live)

Total Revenue
$410,983,006,208
EBITDA
$7,071,000,064
Free Cash Flow
$6,801,249,792
Enterprise Value
$112,022,446,080
Total Cash
$5,164,000,256
Total Debt
$11,795,999,744
Shares Out
116,590,363
Trailing EPS
$37.26
Book Value
$-36.55
ROE
ROA
4.7%
Div Yield
0.43%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Mar 2026 403,430,000,000 6,454,000,000 4,762,000,000 82,323,000,000 83,157,000,000 6,155,000,000
Mar 2025 359,051,000,000 4,816,000,000 3,295,000,000 75,140,000,000 76,834,000,000 6,085,000,000
Mar 2024 308,951,000,000 4,171,000,000 3,002,000,000 67,443,000,000 69,042,000,000 4,314,000,000
Mar 2023 276,711,000,000 4,582,000,000 3,560,000,000 62,320,000,000 63,810,000,000 5,159,000,000

TTM Snapshot

Revenues TTM
$315,296,000,000
NetIncome TTM
$2,540,000,000
OpCashFlow TTM
$0
Assets (Latest)
$75,140,000,000
Forward EPS
$50.53

Max Pain — expiry 2026-08-21

max pain strike: $830.00 · spot: $856.69 · call oi: 4,089 · put oi: 2,858
Expected Move to 2026-08-21: ±$33.70 (3.93%) — implied range $822.99$890.39 · ATM straddle on $860.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
TEL TE Connectivity plc $62.11B $214.20
GWW W.W. GRAINGER, INC. $61.61B $1304.88
COR Cencora, Inc. $59.95B $314.17
CAH CARDINAL HEALTH INC $54.46B $234.16
FERG Ferguson Enterprises Inc. /DE/ $47.43B $245.18

News headlines (Yahoo Finance, 1h cache)

McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
2026-08-07 16:45 · Yahoo
MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised
2026-08-06 15:41 · Yahoo
S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results
2026-08-11 13:16 · Yahoo
QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered
2026-08-10 17:29 · Yahoo
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
2026-08-10 17:27 · Yahoo
McKesson Q1 Earnings Call Highlights
2026-08-08 18:03 · Yahoo
How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story
2026-08-08 09:11 · Yahoo
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
2026-08-07 20:44 · Yahoo
Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?
2026-08-07 18:20 · Yahoo
10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up
2026-08-07 17:57 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.